(Q34539534)

2 August 2017

1 reference

title

High-dose chemoradiotherapy (HDC) in the Ewing family of tumors (EFT). (English)

1 reference

2 August 2017

0 references

Burdach S

1

1 reference

2 August 2017

Jürgens H

series ordinal

2

1 reference

2 August 2017

language of work or name

1 reference

1 February 2002

1 reference

Critical Reviews in Oncology Hematology

2 August 2017

published in

1 reference

2 August 2017

volume

41

1 reference

2 August 2017

issue

2

1 reference

2 August 2017

page(s)

169-189

1 reference

The role of megatherapy with autologous bone marrow rescue in solid tumours of childhood.

2 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Autologous stem cell transplantation in solid tumours of childhood

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Ewing sarcoma 11;22 translocation produces a chimeric transcription factor that requires the DNA-binding domain encoded by FLI1 for transformation.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

A novel effector domain from the RNA-binding protein TLS or EWS is required for oncogenic transformation by CHOP

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Neuropeptide Y inhibits vasoactive intestinal peptide- and dopamine-induced cyclic AMP formation in human Ewing's sarcoma WE-68 cells

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Pediatric peripheral neuroectodermal tumors, oncogenes, and differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

A Ewing's sarcoma cell line showing some, but not all, of the traits of a cholinergic neuron

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

A second Ewing's sarcoma translocation, t(21;22), fuses the EWS gene to another ETS-family transcription factor, ERG

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

The macrophage and B cell-specific transcription factor PU.1 is related to the ets oncogene

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

The Drosophila 74EF early puff contains E74, a complex ecdysone-inducible gene that encodes two ets-related proteins

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Requirement of ets-2 expression for Xenopus oocyte maturation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Sequence-specific binding of human Ets-1 to the T cell receptor alpha gene enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Xl-fli, the Xenopus homologue of the fli-1 gene, is expressed during embryogenesis in a restricted pattern evocative of neural crest cell distribution

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Combinatorial generation of variable fusion proteins in the Ewing family of tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

EWS-erg and EWS-Fli1 fusion transcripts in Ewing's sarcoma and primitive neuroectodermal tumors with variant translocations

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Variability of EWS chimaeric transcripts in Ewing tumours: a comparison of clinical and molecular data.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Diagnostic value of the molecular genetic detection of the t(11;22) translocation in Ewing's tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Does expression of different EWS chimeric transcripts define clinically distinct risk groups of Ewing tumor patients?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

DNA-binding and transcriptional activation properties of the EWS-FLI-1 fusion protein resulting from the t(11;22) translocation in Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

An association between viral genes and human oncogenic alterations: the adenovirus E1A induces the Ewing tumor fusion transcript EWS-FLI1.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Malignant peripheral neuroectodermal tumours of childhood and adolescence

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma. A report from the Kiel Pediatric Tumor Registry

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Prognostic value of histopathology in Ewing's sarcoma. Long-term follow-up of distal extremity primary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Neuroectodermal differentiation in Ewing's sarcoma family of tumors does not predict tumor behavior

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Relation of neurological marker expression and EWS gene fusion types in MIC2/CD99-positive tumors of the Ewing family.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

The James Ewing lecture. The relationship between tumor mass and resistance to chemotherapy. Implications for surgical adjuvant treatment of cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Optimal scheduling of total body irradiation in the treatment of Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Cell kinetic-based scheduling of chemotherapy: hypothesis versus reality

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Therapy for localized Ewing's sarcoma of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Ewing's sarcoma: Ten-year experience with adjuvant chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

EICESS 92 (European Intergroup Cooperative Ewing's Sarcoma Study)-- preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Very intensive, short-term chemotherapy for children and adolescents with metastatic sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Allogeneic and autologous stem-cell transplantation in advanced Ewing tumors. An update after long-term follow-up from two centers of the European Intergroup study EICESS. Stem-Cell Transplant Programs at Düsseldorf University Medical Center, German

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Radiotherapy and high-dose chemotherapy in advanced Ewing's tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Second malignancies after Ewing's sarcoma: radiation dose-dependency of secondary sarcomas

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

[Ewing sarcoma. Diagnostic imaging]

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Multimodality diagnostics and megatherapy in poor prognosis Ewing's tumor patients. A single-center report

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Comparison of STIR and spin-echo MR imaging at 1.5 T in 45 suspected extremity tumors: lesion conspicuity and extent

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Heterogeneous signal in bone marrow on MRI of children's feet: a normal finding?

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

MR imaging of bone marrow in children with osteosarcoma: effect of granulocyte colony-stimulating factor

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Changes in tumor perfusion induced by chemotherapy in bone sarcomas: color Doppler flow imaging compared with contrast-enhanced MR imaging and three-phase bone scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Fat-saturated contrast-enhanced T1-weighted MRI in evaluation of osteosarcoma and Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Detection of areas with viable remnant tumor in postchemotherapy patients with Ewing's sarcoma by dynamic contrast-enhanced MRI using pharmacokinetic modeling

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Increased confidence of diagnosis of Ewing sarcoma using T2-weighted MR images

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Monitoring the effect of chemotherapy in Ewing's sarcoma of bone with MR imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Classification of histopathologic changes following chemotherapy in Ewing's sarcoma of bone

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Dynamic contrast-enhanced MR imaging of musculoskeletal tumors: basic principles and clinical applications.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Use of MR imaging to assess results of chemotherapy for Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

[MRI diagnosis in longitudinal stress fractures: differential diagnosis of Ewing sarcoma]

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Neoplasms in a pediatric population: 2-[F-18]-fluoro-2-deoxy-D-glucose PET studies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

[The Cooperative Ewing Sarcoma Study CESS 81 of the German Pediatric Oncology Society--analysis after 4 years]

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Multidisciplinary treatment of primary Ewing's sarcoma of bone. A 6-year experience of a European Cooperative Trial

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

The histological response to chemotherapy as a predictor of the oncological outcome of operative treatment of Ewing sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Evaluation of prognostic factors in a tumor volume-adapted treatment strategy for localized Ewing sarcoma of bone: the CESS 86 experience. Cooperative Ewing Sarcoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Alternative donor bone marrow transplantation for children with juvenile myelomonocytic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Long-term results from the first UKCCSG Ewing's Tumour Study (ET-1). United Kingdom Children's Cancer Study Group (UKCCSG) and the Medical Research Council Bone Sarcoma Working Party

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Ewing's family of tumors in adults: multivariate analysis of survival and long-term results of multimodality therapy in 182 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Outcome in 43 children presenting with metastatic Ewing sarcoma: the St. Jude Children's Research Hospital experience, 1962 to 1992.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Pelvic Ewing sarcoma: a retrospective analysis of 241 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Significance of surgical margin on the prognosis of patients with Ewing's sarcoma. A report from the Cooperative Ewing's Sarcoma Study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Italian Cooperative Study for the treatment of children and young adults with localized Ewing sarcoma of bone: a preliminary report of 6 years of experience

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Morphological grades of regression in osteosarcoma after polychemotherapy - study COSS 80

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Ewing's sarcoma treatment in Scandinavia 1984-1990--ten-year results of the Scandinavian Sarcoma Group Protocol SSGIV

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Prognostic factors in patients with localized Ewing's sarcoma: the effect on survival of actual received drug dose intensity and of histologic response to induction therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Factors associated with tumor volume and primary metastases in Ewing tumors: results from the (EI)CESS studies

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

[Results of treatment of primary metastatic Ewing sarcoma. A retrospective analysis of 48 patients]

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

[Results of treatment of primary exclusively pulmonary metastatic Ewing sarcoma. A retrospective analysis of 41 patients]

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Myeloablative radiochemotherapy and hematopoietic stem-cell rescue in poor-prognosis Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

[High-dosage chemotherapy in primary metastasized and relapsed Ewing's sarcoma. (EI)CESS]

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

EWS-FLI1 fusion transcript structure is an independent determinant of prognosis in Ewing's sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

The Ewing family of tumors and the search for the Achilles' heel.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Sequential half-body irradiation as systemic treatment of progressive Ewing sarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

In vitro radiation studies on Ewing's sarcoma cell lines and human bone marrow: application to the clinical use of total body irradiation (TBI)

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Ewing's sarcoma: a trial of adjuvant chemotherapy and sequential half-body irradiation

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Intensive melphalan chemotherapy and cryopreserved autologous bone marrow transplantation for the treatment of refractory cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Busulphan is active against neuroblastoma and medulloblastoma xenografts in athymic mice at clinically achievable plasma drug concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Phase II study of high-dose thiotepa and hematopoietic stem cell transplantation in children with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Fractionated high-dose cyclophosphamide for advanced pediatric solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Five-year results in Ewing's sarcoma. The Scandinavian Sarcoma Group experience with the SSG IX protocol

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Haemopoietic recovery in Ewing's sarcoma after intensive combination therapy and autologous marrow infusion

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Autologous bone marrow transplantation in paediatric solid tumours

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Total-body irradiation and autologous bone marrow transplant in the treatment of high-risk Ewing's sarcoma and rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Busulfan, melphalan, and thiotepa with or without total marrow irradiation with hematopoietic stem cell rescue for poor-risk Ewing-Sarcoma-Family tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

High-dose busulfan and cyclophosphamide with autologous bone marrow transplantation support in advanced malignancies in children: a phase II study

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

High-dose busulphan/melphalan with autologous stem cell rescue in Ewing's sarcoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

High-dose busulfan/melphalan as conditioning for autologous PBPC transplantation in pediatric patients with solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Phase I study of high-dose thiotepa with busulfan, etoposide, and autologous stem cell support in children with disseminated solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Control of a human tumour (Ewing sarcoma) in mice by a single lethal dose of dimethyl-myleran and bone marrow

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Xenografts in pharmacologically immunosuppressed mice as a model to test the chemotherapeutic sensitivity of human tumors

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Interferon gamma and tumour necrosis factor alpha induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killing

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

[Immune stimulation with interleukin-2 after autologous stem cell transplantation in children and adolescents with solid tumors]

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Induction of a CD3+/CD56+ lymphocyte population following gene therapy with transgenic IL-2 secreting fibroblasts in a child with peripheral neuroectodermal malignancy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Interleukin-2 gene-modified allogeneic tumor cells for treatment of relapsed neuroblastoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Targeting tumor specific translocations in sarcomas in pediatric patients for immunotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Incidence of bone marrow involvement in Ewing's sarcoma: value of extensive investigation of the bone marrow.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

Circulating CD34+ cell counts as predictive parameter for the efficacy of peripheral stem cell apheresis in Ewing tumor patients

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

RT-PCR evaluation of peripheral blood, bone marrow and peripheral blood stem cells in children and adolescents undergoing VACIME chemotherapy for Ewing's sarcoma and alveolar rhabdomyosarcoma

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

New strategies for the application of high-dose chemotherapy with haematopoietic support in paediatric solid tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS1040-8428%2801%2900154-8

7 January 2021

10.1016/S1040-8428(01)00154-8

Identifiers

DOI

1 reference

2 August 2017

1 reference